-
1دورية أكاديمية
المصدر: Cancer Management and Research, Vol Volume 13, Pp 7139-7148 (2021)
مصطلحات موضوعية: lenvatinib, radioiodine-refractory differentiated thyroid carcinoma (rrdtc), disease control rate (dcr), progression-free survival (pfs), overall survival (os), Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282
وصف الملف: electronic resource
-
2
المؤلفون: Yen-Hao Chen, Che-Wei Wu, Pei-Wen Wang, He-Jiun Jiang, Yen-Hsiang Chang, Pi-Jung Hsiao
المصدر: Cancer Management and Research
مصطلحات موضوعية: medicine.medical_specialty, radioiodine-refractory differentiated thyroid carcinoma, overall survival, Urology, lenvatinib, PFS, Efficacy, chemistry.chemical_compound, RRDTC, Refractory, Medicine, Progression-free survival, Adverse effect, Original Research, business.industry, Maintenance dose, OS, DCR, Discontinuation, Oncology, chemistry, Tolerability, disease control rate, Cancer Management and Research, business, Lenvatinib, progression-free survival
وصف الملف: text/html
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::34e046905eb6ef1be34718cc72a61e05Test
https://doi.org/10.2147/cmar.s326255Test